NCT06547684 Extracorporeal Shock Wave Therapy on Spastic Equinus Foot in Stroke Patients
| NCT ID | NCT06547684 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Teresa Mateu Campos |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2020-08-28 |
| Primary Completion | 2024-09-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2020-08-28 with a primary completion date of 2024-09-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate long term effects of focused extracorporeal shock wave therapy (fESWT) on triceps surae spasticity in stroke patients according to the number of sessions applied. Hypothesis: 3 sessions of fESWT on equinus foot in stroke patients improve spasticity and functionality for longer term than 1 session of fESWT.
Eligibility Criteria
Inclusion Criteria: * Age greater than 18 years old * Time from stroke (ischemic o hemorrhagic) onset of at least 6 months * Spastic equinus foot: triceps surae tone grade at least 1+ on the MAS score * Ability to walk alone with or without aids Exclusion Criteria: * Fixed ankle joint contracture * Severe medical problems * Treatment of the affected leg with botulinum toxin in the las 6 months * Cognitive impairment
Contact & Investigator
Teresa Mª Mateu Campos
PRINCIPAL INVESTIGATOR
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Frequently Asked Questions
Who can join the NCT06547684 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06547684 currently recruiting?
Yes, NCT06547684 is actively recruiting participants. Contact the research team at teremateuc@gmail.com for enrollment information.
Where is the NCT06547684 trial being conducted?
This trial is being conducted at Vila-real, Spain.
Who is sponsoring the NCT06547684 clinical trial?
NCT06547684 is sponsored by Teresa Mateu Campos. The principal investigator is Teresa Mª Mateu Campos at Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.